Durmaz, O. Et Al. 2011. Recombinant Human Erythropoietin beta: The Effect of Weekly Dosing on Anemia, Quality of Life, and Long-Term Outcomes in Pediatric Cancer Patients. PEDIATRIC HEMATOLOGY AND ONCOLOGY , vol.28, no.6 , 461-468.

Durmaz, O., Demirkaya, M., & Sevinir, B. B., (2011). Recombinant Human Erythropoietin beta: The Effect of Weekly Dosing on Anemia, Quality of Life, and Long-Term Outcomes in Pediatric Cancer Patients. PEDIATRIC HEMATOLOGY AND ONCOLOGY , vol.28, no.6, 461-468.

Durmaz, Oguzhan, Metin Demirkaya, And BETÜL BERRİN SEVİNİR. "Recombinant Human Erythropoietin beta: The Effect of Weekly Dosing on Anemia, Quality of Life, and Long-Term Outcomes in Pediatric Cancer Patients," PEDIATRIC HEMATOLOGY AND ONCOLOGY , vol.28, no.6, 461-468, 2011

Durmaz, Oguzhan Et Al. "Recombinant Human Erythropoietin beta: The Effect of Weekly Dosing on Anemia, Quality of Life, and Long-Term Outcomes in Pediatric Cancer Patients." PEDIATRIC HEMATOLOGY AND ONCOLOGY , vol.28, no.6, pp.461-468, 2011

Durmaz, O. Demirkaya, M. And Sevinir, B. B. (2011) . "Recombinant Human Erythropoietin beta: The Effect of Weekly Dosing on Anemia, Quality of Life, and Long-Term Outcomes in Pediatric Cancer Patients." PEDIATRIC HEMATOLOGY AND ONCOLOGY , vol.28, no.6, pp.461-468.

@article{article, author={Oguzhan Durmaz Et Al. }, title={Recombinant Human Erythropoietin beta: The Effect of Weekly Dosing on Anemia, Quality of Life, and Long-Term Outcomes in Pediatric Cancer Patients}, journal={PEDIATRIC HEMATOLOGY AND ONCOLOGY}, year=2011, pages={461-468} }